Allergan Aesthetics invites consumers to participate in the faces of Natrelle® campaign

• Consumers can apply today for an opportunity to appear in an upcoming Natrelle campaign^® and share their personal stories.
• Candy^® is the #1 selected breast implant by US doctors’ drivers^* Offering the larger range of options for each curve, every shape, for each body.

Irvine, California.; February 6, 2025 /Tower/ – Allergan Aesthetics, an ABBVIE (NYSE: ABBV) company, announced a national open -casting call in search of the next Faces of Natrelle^®encouraging women who have experienced breast reconstruction and/or increase to share their inspirational stories and appear in the brand’s upcoming campaign. As an extension of Candy^® For each body The platform that started last year, the initiative continues to boost the company’s commitment to promote a comprehensive and varied space where all women feel they see and are valued.

“THE Faces of Natrelle^® The campaign is more than just celebrating the natural beauty, “he said Carrie stromSenior Vice President, Abbvie and President of Global Allergan Aesthetics. “We appreciate the strength, durability and uniqueness of women who use our products. Through this campaign, our goal is to strengthen women who think of breast surgery with the demystification of treatment, encouraging transparency and The celebration of the diversity of every curve, every shape and every body. “

THE Faces of Natrelle^® The casting call is open now 28 February 2025 closing 11:59 PM EDT. Women aged 22 and over who have recently planned or submitted Candy^® Breast increase or reconstruction are encouraged to learn more about eligibility and method of application Faces.natrelle.com. It is only for US audiences. The final cast will be announced later this year.

To find out more about treatment with Candy^® or to find a provider, visit Natrelle.comand follow together on Instagram @natrellebreastaugmentation and @NatrellebreastReContruction.

*Based on surgeon’s survey data, January 2021 (N = 114) and plastic monthly monitoring DOF January 2021.

Candy^® Breast Important Security Information and Approved Uses

Breast implants are not considered life devices. The more people have, the greater the chances of developing complications, some of which will require more surgery.

Breast implants have been associated with the development of an immune system cancer called a detailed lymphoma-related lymphoma cell (BIA-ALCL). This cancer most often occurs in patients with textured breast implants from the smooth implants, although the rates are not well defined. Some patients have died of BIA-ALCL.

Patients receiving breast implants have reported a variety of systemic symptoms, such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases and more. The individual risk of patient to develop these symptoms has not been well established. Some patients report complete solving symptoms when implants are removed without replacement.

Who can get breast implants?

Candy^® Breast implants have been approved for the following:

• Increase in breast For women at least 22 years old for silicone -filled implants and for women at least 18 years for implants filled with saline. Breast increase involves primary breast increase to increase breast size and review surgery to correct or improve the result of a primary breast increase
• Reconstruction of the breast. This includes the primary breast reconstruction to replace the breast tissue removed due to cancer or trauma or which failed to grow properly due to severe breast abnormality. This also includes review surgery to correct or improve the result of a primary breast reconstruction

Who should not get breast implants?

Breast implant surgery should not be performed in:

• Women with active infection anywhere in their body
• Women with existing cancer or provocative breast who have not received sufficient treatment for these conditions
• Women who are currently pregnant or nurses

What should I say to my doctor?

Tell your doctor if you have any of the following conditions, as the risks of breast implant surgery may be higher:

• Autoimmune diseases (eg wolf and scleroderma)
• A weakened immune system (eg taking medications to reduce body immune response)
• Scheduled Chemotherapy or Radiotherapy After Placing Breast Implant
• Conditions or medicines that interfere with wound healing and blood clotting
• Reduced blood supply to breast tissue
• Clinical diagnosis of depression or other mental health disorders, including deforming body disorder and eating disorders
• Those with a diagnosis of depression or other mental health disorders should wait for the resolution or stabilization of these situations before breast implantation surgery

What else should I consider?

• There is a warning about breast implants. Please refer to Bold Text at the beginning
• Many changes in your breasts after implantation are irreversible. If you later choose to remove your implants and not be replaced, you may face the split, rod, crumpled or other cosmetic changes that may be permanent
• Breast implantation is not likely not to be a lump sum surgery. Larger implants are in force, the greater the potential risk of complications. You will probably need additional surgeries on your breasts due to complications or unacceptable cosmetic results. Thus, you should also consider complications for later (revision) surgery, as you may face these risks in the future
• Cancer treatments and surgery will affect the effect and timing of breast reconstruction
• Breast implants may affect your ability to breastfeed either by reducing or eliminating milk production
• The rupture of a silicone breast implant is more often silent. Even if you do not have symptoms, you should have your first ultrasound or magnetic resonance imaging in 5 to 6 years after your initial implant surgery and then every 2 to 3 years later, regardless of whether your implants are for increase or reconstruction. If you have symptoms or uncertain effects of ultrasound for breaking breaking breast, a magnetic resonance imaging is recommended. Additional visualization may be required depending on your medical history and condition. The consequences for the health of a breaking of a silicone breast implant have not been fully established
• The usual sorting mammography for breast cancer will be more difficult and implants can rupture during the procedure. Run the self-examination each month for cancer control and ask your surgeon to help you distinguish the implant from your breast tissue. It should be reported to your surgeon to report the clots, persistent pain, swelling, sclerosis or implant changes and possibly evaluated with imaging

What are the key complications with breast implants?
The basic complications include reinstalling, removing implants with or without replacement, implantation with implants full of silicone, deflation of implants full of saline and ceilings (severe scar tissue). Other complications include chest pain, swelling, asymmetry, crumpling/ripple, implant nipple complications, hypertrophic scars and visibility/implant visibility.

Talk to your doctor about other complications.

For more information, see patient leaflets in www.allergan.com/products.

To report a problem with Candy^® Breast Implants, Call Allergan^® At 1-800-624-4261.

The sale and distribution of Candy^® Breast implants are limited to licensed doctors providing information to patients about the dangers and benefits of breast implant surgery.

For the aesthetics of Allergan
At Allergan Aesthetics, an AbbVie company, we develop, build and market a portfolio with leading brands and aesthetics. The portfolio of our aesthetics includes facial injectors, body contours, plastic, skin care and much more. Our goal is to consistently provide our customers innovation, education, excellent services and commitment to excellence, all with personal touch. For more information, visit www.allerganaESTETHETICS.com.

For Abbvie
AbbVie’s mission is to discover and deliver innovative medicines and solutions that today resolve serious health issues and face the medical challenges of tomorrow. We try to have a remarkable impact on people’s lives in various basic therapeutic areas – immunology, oncology, neuroscience and eye care – and products and services in the Allergan Aesthetics portfolio. For more information about ABBVIE, visit us www.abbvvvie.com. Follow @ABBVIE ON LinkedIn, Facebook; Instagram; X (former twitter)and YouTube.

Contacts

Media Aesthetics Allergan:
Inflatable
+1 (949) 413-6091
Garrett_ember@allergan.com

Abbvie Investors:

Liz shea
+1 (847) 935-22111
Liz.shea@abbvvie.com

AbbVie source